ATE255589T1 - Kristallin form i von clarithromycin - Google Patents
Kristallin form i von clarithromycinInfo
- Publication number
- ATE255589T1 ATE255589T1 AT97934307T AT97934307T ATE255589T1 AT E255589 T1 ATE255589 T1 AT E255589T1 AT 97934307 T AT97934307 T AT 97934307T AT 97934307 T AT97934307 T AT 97934307T AT E255589 T1 ATE255589 T1 AT E255589T1
- Authority
- AT
- Austria
- Prior art keywords
- clarithromycin
- crystalline form
- methylerythromycin
- antiobiotic
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/681,723 US5858986A (en) | 1996-07-29 | 1996-07-29 | Crystal form I of clarithromycin |
PCT/US1997/013128 WO1998004573A1 (en) | 1996-07-29 | 1997-07-25 | Crystal form i of clarithromycin |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE255589T1 true ATE255589T1 (de) | 2003-12-15 |
Family
ID=24736505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97934307T ATE255589T1 (de) | 1996-07-29 | 1997-07-25 | Kristallin form i von clarithromycin |
Country Status (18)
Country | Link |
---|---|
US (1) | US5858986A (de) |
EP (1) | EP0915898B1 (de) |
JP (2) | JP2000515894A (de) |
KR (1) | KR100498800B1 (de) |
CN (2) | CN1754884A (de) |
AT (1) | ATE255589T1 (de) |
AU (1) | AU3739797A (de) |
BR (1) | BR9710768A (de) |
CA (2) | CA2258606C (de) |
CZ (1) | CZ294446B6 (de) |
DE (1) | DE69726577T2 (de) |
DK (1) | DK0915898T3 (de) |
ES (1) | ES2173056T3 (de) |
IL (1) | IL127581A (de) |
NZ (1) | NZ333380A (de) |
PT (1) | PT915898E (de) |
TR (1) | TR199900083T2 (de) |
WO (1) | WO1998004573A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5945405A (en) * | 1997-01-17 | 1999-08-31 | Abbott Laboratories | Crystal form O of clarithromycin |
KR100377159B1 (ko) * | 1998-09-09 | 2003-08-19 | 한미약품공업 주식회사 | 잔류 용매가 없는 클라리스로마이신의 결정형 2의 제조 방법 |
GB9827355D0 (en) | 1998-12-11 | 1999-02-03 | Biochemie Sa | Organic compounds |
AU4942800A (en) * | 1999-06-11 | 2001-01-02 | Ranbaxy Laboratories Limited | Novel amorphous form of clarithromycin |
KR100336447B1 (ko) * | 1999-11-24 | 2002-05-15 | 민경윤 | 클라리스로마이신의 개선된 제조방법 |
US6627743B1 (en) | 1999-12-03 | 2003-09-30 | Abbott Laboratories | 6-O-methylerythromycin A crystal form III |
IL150227A0 (en) * | 1999-12-16 | 2002-12-01 | Teva Pharma | Processes for preparing clarithromycin polymorphs and novel polymorph iv |
KR20020071012A (ko) * | 2000-01-11 | 2002-09-11 | 테바 파마슈티컬 인더스트리즈 리미티드 | 클래리스로마이신 다형체의 제조 방법 |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6544555B2 (en) * | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
PL366021A1 (en) | 2000-02-29 | 2005-01-24 | Teva Pharmaceutical Industries Ltd. | Processes for preparing clarithromycin and clarithromycin intermediate, essentially oxime-free clarithromycin, and pharmaceutical composition comprising the same |
CN1193036C (zh) * | 2000-03-15 | 2005-03-16 | 韩美药品工业株式会社 | 制备甲红霉素-克拉霉素ⅱ型晶体的方法 |
DE60138876D1 (de) * | 2000-03-28 | 2009-07-16 | Sandoz Ag | Geschmackmaskierte granulierte teilchen |
KR20000037126A (ko) * | 2000-04-08 | 2000-07-05 | 김용규 | 6-메틸 에리스로마이신 a의 제조방법 |
US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
WO2002038577A2 (en) * | 2000-10-13 | 2002-05-16 | Advancis Pharmaceuticals | Extended release erythromycin derivatives |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
KR100408848B1 (ko) * | 2001-03-12 | 2003-12-06 | 주식회사 씨트리 | 클래리스로마이신의 정제방법 |
CN100427498C (zh) * | 2003-03-02 | 2008-10-22 | 王凌峰 | 克拉霉素a型结晶 |
WO2005009368A2 (en) * | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009364A2 (en) * | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005009365A2 (en) * | 2003-07-21 | 2005-02-03 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005016311A1 (en) * | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
AU2004264356B2 (en) | 2003-08-12 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005023184A2 (en) * | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
WO2005027877A1 (en) * | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
WO2005061524A2 (en) * | 2003-12-22 | 2005-07-07 | Ranbaxy Laboratories Limited | Process for the preparation of form ii clarithromycin |
US20050142187A1 (en) * | 2003-12-24 | 2005-06-30 | Treacy Donald J.Jr. | Enhanced absorption of modified release dosage forms |
WO2006014427A1 (en) * | 2004-07-02 | 2006-02-09 | Advancis Pharmaceutical Corporation | Tablet for pulsed delivery |
US20060111560A1 (en) * | 2004-11-01 | 2006-05-25 | Glenmark Pharmaceuticals Limited | Process for the preparation of crystalline form II of clarithromycin |
JP2009500356A (ja) * | 2005-07-07 | 2009-01-08 | エラン ファーマ インターナショナル リミテッド | ナノ粒子クラリスロマイシン製剤 |
WO2007036951A2 (en) * | 2005-08-31 | 2007-04-05 | Alembic Limited | Process to obtain 6-o-methylerythromycin a (clarithromycin)_form ii |
US8778924B2 (en) * | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
DE102007016367A1 (de) | 2007-04-03 | 2008-10-09 | Grünenthal GmbH | Polymorph von Clarithromycin (Form V) |
US20090054634A1 (en) * | 2007-08-09 | 2009-02-26 | Vinod Kumar Kansal | Process for the preparation of clarithromycin |
EP2030613A1 (de) | 2007-08-17 | 2009-03-04 | Abbott GmbH & Co. KG | Herstellung von Zusammensetzungen mit hauptsächlich nichtkristallinen eingebetteten Makrolid-Antibiotika |
CN101525360B (zh) * | 2008-03-06 | 2012-10-10 | 刘力 | 大环内酯类有机酸盐的水合物及其制备和用途 |
CN101812102B (zh) * | 2009-02-21 | 2015-09-02 | 王凌峰 | 6-o-甲基红霉素a晶型v |
CN102532222B (zh) * | 2010-12-21 | 2015-06-17 | 北大方正集团有限公司 | 一种麦迪霉素的结晶方法 |
US9119769B2 (en) | 2011-12-30 | 2015-09-01 | The Curators Of The University Of Missouri | Method for transforming pharmaceutical crystal forms |
CN102942607A (zh) * | 2012-11-28 | 2013-02-27 | 宁夏启元药业有限公司 | 一种复合溶剂结晶红霉素的方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4331803A (en) | 1980-06-04 | 1982-05-25 | Taisho Pharmaceutical Co., Ltd. | Novel erythromycin compounds |
JPS5782400A (en) | 1980-11-12 | 1982-05-22 | Taisho Pharmaceut Co Ltd | Erythromycin derivative |
JPS60214796A (ja) * | 1984-04-06 | 1985-10-28 | Taisho Pharmaceut Co Ltd | 6−0−メチルエリスロマイシン類の製法 |
JPS61103890A (ja) | 1984-10-26 | 1986-05-22 | Taisho Pharmaceut Co Ltd | 6−0−メチルエリスロマイシンa誘導体 |
US4670549A (en) * | 1985-03-18 | 1987-06-02 | Taisho Pharmaceutical Co., Ltd. | Method for selective methylation of erythromycin a derivatives |
DE3782994T2 (de) | 1986-09-18 | 1993-04-08 | Taisho Pharma Co Ltd | Erythromycin-a-derivate und verfahren zu ihrer herstellung. |
JPH0755958B2 (ja) * | 1986-10-03 | 1995-06-14 | 大正製薬株式会社 | エリスロマイシンa誘導体の製造方法 |
JP2526951B2 (ja) * | 1986-12-17 | 1996-08-21 | 大正製薬株式会社 | エリスロマイシンa誘導体およびその製造方法 |
KR960000434B1 (ko) | 1986-12-17 | 1996-01-06 | 다이쇼 세이야꾸 가부시끼가이샤 | 에리스로마이신 a유도체 및 그의 제조 방법 |
JP2782793B2 (ja) * | 1988-06-15 | 1998-08-06 | 大正製薬株式会社 | エリスロマイシンa誘導体およびその製造方法 |
US5872229A (en) * | 1995-11-21 | 1999-02-16 | Abbott Laboratories | Process for 6-O-alkylation of erythromycin derivatives |
US5837829A (en) | 1996-04-02 | 1998-11-17 | Abbott Laboratories | 9-oximesilyl erythromycin a derivatives |
US5719272A (en) | 1996-04-02 | 1998-02-17 | Abbott Laboratories | 2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives |
-
1996
- 1996-07-29 US US08/681,723 patent/US5858986A/en not_active Expired - Lifetime
-
1997
- 1997-07-25 PT PT97934307T patent/PT915898E/pt unknown
- 1997-07-25 NZ NZ333380A patent/NZ333380A/xx not_active IP Right Cessation
- 1997-07-25 BR BR9710768A patent/BR9710768A/pt not_active Application Discontinuation
- 1997-07-25 CA CA002258606A patent/CA2258606C/en not_active Expired - Lifetime
- 1997-07-25 TR TR1999/00083T patent/TR199900083T2/xx unknown
- 1997-07-25 DE DE69726577T patent/DE69726577T2/de not_active Revoked
- 1997-07-25 AU AU37397/97A patent/AU3739797A/en not_active Abandoned
- 1997-07-25 CZ CZ199999A patent/CZ294446B6/cs not_active IP Right Cessation
- 1997-07-25 EP EP97934307A patent/EP0915898B1/de not_active Revoked
- 1997-07-25 CA CA002627035A patent/CA2627035A1/en not_active Abandoned
- 1997-07-25 AT AT97934307T patent/ATE255589T1/de not_active IP Right Cessation
- 1997-07-25 WO PCT/US1997/013128 patent/WO1998004573A1/en not_active Application Discontinuation
- 1997-07-25 DK DK97934307T patent/DK0915898T3/da active
- 1997-07-25 JP JP10509015A patent/JP2000515894A/ja active Pending
- 1997-07-25 IL IL12758197A patent/IL127581A/en not_active IP Right Cessation
- 1997-07-25 ES ES97934307T patent/ES2173056T3/es not_active Expired - Lifetime
- 1997-07-25 KR KR10-1999-7000715A patent/KR100498800B1/ko not_active IP Right Cessation
- 1997-07-25 CN CNA2005100859158A patent/CN1754884A/zh active Pending
- 1997-07-25 CN CN971968195A patent/CN1216892C/zh not_active Expired - Lifetime
-
2009
- 2009-12-10 JP JP2009280116A patent/JP5290136B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
WO1998004573A1 (en) | 1998-02-05 |
CN1216892C (zh) | 2005-08-31 |
CN1229411A (zh) | 1999-09-22 |
JP2010090156A (ja) | 2010-04-22 |
IL127581A (en) | 2004-06-20 |
EP0915898A1 (de) | 1999-05-19 |
CZ9999A3 (cs) | 1999-05-12 |
CA2258606C (en) | 2003-05-27 |
AU3739797A (en) | 1998-02-20 |
CA2258606A1 (en) | 1998-02-05 |
BR9710768A (pt) | 1999-08-17 |
DK0915898T3 (da) | 2004-02-16 |
KR100498800B1 (ko) | 2005-07-01 |
EP0915898B1 (de) | 2003-12-03 |
JP5290136B2 (ja) | 2013-09-18 |
DE69726577D1 (en) | 2004-01-15 |
DE69726577T2 (de) | 2004-11-04 |
IL127581A0 (en) | 1999-10-28 |
PT915898E (pt) | 2004-02-27 |
JP2000515894A (ja) | 2000-11-28 |
CN1754884A (zh) | 2006-04-05 |
TR199900083T2 (xx) | 1999-04-21 |
CA2627035A1 (en) | 1998-02-05 |
US5858986A (en) | 1999-01-12 |
ES2173056T3 (es) | 2004-06-16 |
CZ294446B6 (cs) | 2005-01-12 |
NZ333380A (en) | 2000-01-28 |
KR20000029644A (ko) | 2000-05-25 |
ES2173056T1 (es) | 2002-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE255589T1 (de) | Kristallin form i von clarithromycin | |
CA2277274A1 (en) | Crystal form 0 of clarithromycin | |
NL980012I2 (nl) | Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen. | |
AP2002002458A0 (en) | Compounds for the treatment of ischemia. | |
EE05091B1 (et) | Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid | |
ES2134801T3 (es) | Monohidrato de hidrocloruro de tiagabina cristalina, su preparacion y su uso. | |
NO980317L (no) | Anvendelse av Calendula-glykosider for behandling av psoriasis | |
NO971625L (no) | Nye peptider med immunomodulatoriske effekter | |
CA2266759A1 (en) | 3-mercaptoacetylamino-1,5-substituted-2-oxo-azepan derivatives useful as inhibitors of matrix metalloproteinase | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
DE69709891T2 (de) | Chitosan enthaltende zusammensetzung | |
CA2386527A1 (en) | Crystal form i of clarithromycin | |
CA2386534A1 (en) | Crystal form ii of clarithromycin and uses thereof | |
BR9902081A (pt) | Combinação de dofetilida e um bloqueador dos canais de cálcio | |
TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0915898 Country of ref document: EP |
|
RZN | Patent revoked |